These findings indicate that abnormal tau in AD may be modulated by the paracrine action of proteins secreted by hUCB-MSCs, and GAL-3 may contribute to the beneficial effects of hUCB-MSCs. The gene discussed is LGALS3; the disease is Alzheimer disease.